Literature DB >> 34130650

Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma.

Zeng-Hong Wu1, Hong-Ming Huang1, Dong-Liang Yang2.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, ranks as the fifth most common cancer and has been the second most frequent cause of cancer-related death. RNA binding proteins (RBPs) are proteins that interact with different classes of RNA and are commonly detected in cells.
METHODS: We used RNA sequencing data from TCGA to display dysfunctional RBPs microenvironments and provide potential useful biomarkers for HCC diagnosis and prognosis.
RESULTS: 330 differently expressed RBPs (208 upregulated and 122 downregulated) were identified. KEGG were mainly enriched in RNA degradation, Influenza A, Hepatitis C, RIG-I-like receptor signaling pathway, Herpes simplex virus 1 infection and RNA transport. CBioPortal results demonstrated that these genes were altered in 50 samples out of 357 HCC patients (14%) and the amplification of BRCA1 was the largest frequent copy-number alteration.
CONCLUSION: Based on the online database, we identified novel RBPs markers for the prognosis of hepatocellular carcinoma.

Entities:  

Keywords:  Hepatocellular carcinoma; Prognosis; RNA binding proteins; TCGA

Year:  2021        PMID: 34130650     DOI: 10.1186/s12876-021-01843-0

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  2 in total

1.  Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.

Authors:  Hua Tian; Chao Ge; Fangyu Zhao; Miaoxin Zhu; Lin Zhang; Qi Huo; Hong Li; Taoyang Chen; Haiyang Xie; Ying Cui; Ming Yao; Jinjun Li
Journal:  Carcinogenesis       Date:  2017-02-01       Impact factor: 4.944

Review 2.  Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging.

Authors:  Mehmet Coskun
Journal:  Exp Clin Transplant       Date:  2017-03       Impact factor: 0.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.